Floatz logo

Rocuronium

Surgery--Complications

Catholic University of the Sacred HeartN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Surgery--Complications cohort.

Asset / SponsorPhaseRating
NEOMYCIN
Helsinki University Central Hospital
Phase 4BB
SUFENTANYL
Peking University First Hospital
Phase 4BB
MACROGOLS
Helsinki University Central Hospital
Phase 4BB
METRONIDAZOLE
Helsinki University Central Hospital
Phase 4BB
DEXAMETHASONE
Peking University First Hospital
Phase 4BB

View all 9 →

Same molecule, other indications

Rocuronium is also rated in:

Surgical ConditionsDormant
BBB
Indicative ·
73 / 100
View asset →
uterine corpus leiomyomaDormant
BB
Indicative ·
69 / 100
View asset →
intestinal obstructionDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →